BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
      • Artificial intelligence
    • Coronavirus
    • Israel
    • IVDs on the rise
    • Radiopharmaceuticals
    • Rise of obesity
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 2, 2023
Home » Topics » Regulatory » Patents

Patents
Patents RSS Feed RSS

Protease inhibitors described by Shionogi

Aug. 30, 1996
No Comments

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996
No Comments

Toyama reveals anti-HIV quinolones

Aug. 30, 1996
No Comments

Tetromycin A: a novel antibacterial agent

Aug. 30, 1996
No Comments

Antifungal agents from Hokko Kagaku

Aug. 30, 1996
No Comments

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996
No Comments

Merck & Co. reports NK1 antagonists

Aug. 30, 1996
No Comments

Novel antitumor compounds claimed by Kyorin/Sagami

Aug. 23, 1996
No Comments

Erythromycin A 9-O-oxime derivatives from Zambon

Aug. 23, 1996
No Comments

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996
No Comments
Previous 1 2 … 3421 3422 3423 3424 3425 3426 3427 3428 3429 … 3491 3492 Next

Popular Stories

  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for December 1, 2023.
  • Joint pain

    Aurinia Therapeutics’ AUR-300 proven useful in systemic sclerosis

    BioWorld Science
    Aurinia Pharmaceuticals Inc. has investigated their CD206 ligand AUR-300 as a novel therapeutic agent for systemic sclerosis treatment.
  • Stock chart with falling red arrow

    ‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s

    BioWorld
    For the second time this week, a contract research organization has come under fire for trial-conduct issues – criticism leveled most recently by Biovie Inc.,...
  • COVID-19 mRNA vaccine vials, syringe

    Japan approves first self-amplifying mRNA COVID-19 vaccine from CSL, Arcturus

    BioWorld
    In a global first, Japan's Ministry of Health, Labor and Welfare has approved CSL Ltd.’s and Arcturus Therapeutics Inc.’s self-amplifying messenger RNA (sa-mRNA)...
  • heart-cardio-data.png

    Avidity, BMS sign $2.3B cardiovascular deal for new RNA class

    BioWorld
    In a deal that could bring Avidity Biosciences Inc. $2.3 billion if all milestones are met, Bristol Myers Squibb Co. gained global rights to Avidity’s antibody...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing